Archer Investment Corp Buys New Position in CVS Health Corporation $CVS

Key Points

• Archer Investment Corp. purchased 24,422 CVS Health shares worth approximately $2.53 million in the second quarter, joining other institutions that increased their positions. Institutional investors collectively own 80.66% of CVS shares.
• CVS reported a strong quarter, with earnings of $2.58 per share versus the $1.87 consensus estimate and revenue of $106.1 billion, up 7.3% year over year. The company maintained fiscal 2026 EPS guidance of $7.90–$8.10.
• CVS pays a quarterly dividend of $0.665, or $2.66 annually, for a 2.9% yield. Analyst sentiment is positive, with a consensus “Moderate Buy” rating and an average price target of $107.17.

Archer Investment Corp purchased a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 24,422 shares of the pharmacy operator's stock, valued at approximately $2,526,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Sei Investments Co. boosted its holdings in shares of CVS Health by 17.4% during the 2nd quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator's stock worth $62,474,000 after buying an additional 134,535 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in CVS Health by 1.2% during the second quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator's stock worth $77,353,000 after acquiring an additional 13,329 shares in the last quarter. Treasurer of the State of North Carolina grew its holdings in CVS Health by 1.3% in the second quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator's stock worth $40,358,000 after purchasing an additional 7,588 shares during the period. HUB Investment Partners LLC raised its holdings in shares of CVS Health by 25.0% during the second quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator's stock valued at $1,039,000 after purchasing an additional 3,011 shares during the period. Finally, Alliancebernstein L.P. increased its position in CVS Health by 8.0% in the 2nd quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator's stock valued at $111,017,000 after buying an additional 119,439 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Trading Up 0.2%

Shares of CVS stock opened at $93.15 on Friday. The company has a market capitalization of $119.14 billion, a PE ratio of 24.64, a price-to-earnings-growth ratio of 0.91 and a beta of 0.61. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68. The business's fifty day moving average is $101.42 and its 200 day moving average is $89.46. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion during the quarter, compared to analysts' expectations of $100.03 billion. During the same period in the previous year, the business earned $1.81 earnings per share. The firm's revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities research analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date was Thursday, July 23rd. CVS Health's payout ratio is presently 70.37%.

Analyst Upgrades and Downgrades

CVS has been the topic of several recent research reports. Wells Fargo & Company increased their price target on CVS Health from $103.00 to $123.00 and gave the stock an "overweight" rating in a report on Monday, July 13th. TD Cowen boosted their price target on shares of CVS Health from $105.00 to $110.00 and gave the company a "buy" rating in a research note on Monday, May 11th. Argus raised their price objective on shares of CVS Health from $104.00 to $114.00 and gave the company a "buy" rating in a research note on Wednesday, August 19th. Wall Street Zen upgraded shares of CVS Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 8th. Finally, Cantor Fitzgerald raised their price target on shares of CVS Health from $100.00 to $110.00 and gave the company an "overweight" rating in a research report on Tuesday, July 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $107.17.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Pharmacy momentum supports the turnaround case. Rising prescription volumes, gains associated with Rite Aid and improving pharmacy profitability could provide support for CVS’s second-half outlook. This adds to the company’s recent earnings momentum, including revenue growth and an earnings beat in its latest reported quarter. How CVS' Pharmacy and Consumer Wellness Is Positioned for H2 2026
• Positive Sentiment: Updated flu vaccines are now available nationwide. CVS Pharmacy and MinuteClinic are offering the 2026–2027 vaccines, while expanded testing and treatment services may increase seasonal customer traffic. A company survey found that more than 60% of consumers are likely to get a flu shot, though the earnings effect is likely to be seasonal and modest. CVS Pharmacy and MinuteClinic Now Offering Updated Flu Vaccines Nationwide
• Positive Sentiment: Value-focused coverage is reinforcing rebound expectations. Zacks characterizes CVS as a potential long-term value stock, while Trefis notes that the company’s historical drawdowns have often eventually recovered. These are sentiment and valuation arguments rather than new financial guidance, but they may attract investors seeking a healthcare turnaround at a relatively reasonable valuation. Why CVS Health Is a Top Value Stock for the Long-Term
• Neutral Sentiment: ACA insurer exits create both opportunity and uncertainty. Cigna, Molina and other carriers are leaving Obamacare exchanges in 2027. The disruption could create enrollment opportunities for Aetna, CVS’s insurance business, but also highlights regulatory, pricing and membership risks across the sector. All the Insurers Exiting ACA Obamacare Exchanges for 2027
• Negative Sentiment: Political pressure on vertically integrated healthcare companies remains a risk. Mark Cuban’s support for breaking up “big medicine” adds to scrutiny of insurers, pharmacy benefit managers and large healthcare platforms. No specific policy action against CVS was announced, but potential structural or regulatory changes could weigh on sentiment. Mark Cuban Backs Plan to Break Up Big Medicine

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source